nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cross-stakeholder approach to improving out-of-hospital cardiac arrest survival
|
Guetterman, Timothy C. |
|
|
266 |
C |
p. 106-119 |
artikel |
2 |
Angiotensin receptor blockers in patients with hypertrophic cardiomyopathy: A comparison of VANISH and INHERIT randomized trials
|
Severinsen, Tino |
|
|
266 |
C |
p. 198-200 |
artikel |
3 |
A review of polypills for the prevention of atherosclerotic cardiovascular disease
|
Agnello, Federica |
|
|
266 |
C |
p. 74-85 |
artikel |
4 |
Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial
|
Harrington, Josephine |
|
|
266 |
C |
p. 25-31 |
artikel |
5 |
Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study
|
Dillen, Daimy M.M. |
|
|
266 |
C |
p. 168-175 |
artikel |
6 |
Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials
|
Newman, Jonathan D. |
|
|
266 |
C |
p. 61-73 |
artikel |
7 |
Cardiovascular disease in Filipino American men and women: A 2023 update
|
Rivera, Frederick Berro |
|
|
266 |
C |
p. 1-13 |
artikel |
8 |
Coronary artery calcium scoring for cardiovascular risk assessment in patients with inflammatory bowel disease
|
Naami, Robert |
|
|
266 |
C |
p. 120-127 |
artikel |
9 |
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey
|
Yao, Hermann |
|
|
266 |
C |
p. 86-97 |
artikel |
10 |
Early computed tomography coronary angiography and preventative treatment in patients with suspected acute coronary syndrome: A secondary analysis of the RAPID-CTCA trial
|
Wang, Kang-Ling |
|
|
266 |
C |
p. 138-148 |
artikel |
11 |
Editorial Board
|
|
|
|
266 |
C |
p. iii-iv |
artikel |
12 |
Effectiveness of the risk stratification proposed by the 2022 European Heart Rhythm Association Expert Consensus statement on arrhythmic mitral valve prolapse
|
L'Hoyes, Wouter |
|
|
266 |
C |
p. 48-60 |
artikel |
13 |
Expectant management of patent ductus arteriosus for preterm infants: A meta-analysis of randomized controlled trials
|
Cheema, Huzaifa Ahmad |
|
|
266 |
C |
p. 179-183 |
artikel |
14 |
Information for Readers
|
|
|
|
266 |
C |
p. v |
artikel |
15 |
Network meta-analysis of temporary mechanical circulatory support in acute myocardial infarction cardiogenic shock
|
Jentzer, Jacob C. |
|
|
266 |
C |
p. 184-187 |
artikel |
16 |
Perioperative prophylactic corticosteroids for cardiac surgery in children: A systematic review and meta-analysis
|
Cheema, Huzaifa Ahmad |
|
|
266 |
C |
p. 159-167 |
artikel |
17 |
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project
|
Solomon, Matthew D. |
|
|
266 |
C |
p. 32-47 |
artikel |
18 |
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation
|
Kir, Devika |
|
|
266 |
C |
p. 14-24 |
artikel |
19 |
Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study
|
Gonsalves, Carin F. |
|
|
266 |
C |
p. 128-137 |
artikel |
20 |
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
|
James, Stefan |
|
|
266 |
C |
p. 188-197 |
artikel |
21 |
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial
|
Puymirat, Etienne |
|
|
266 |
C |
p. 98-105 |
artikel |
22 |
Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure)
|
Flett, Andrew |
|
|
266 |
C |
p. 149-158 |
artikel |
23 |
Table of Contents
|
|
|
|
266 |
C |
p. i-ii |
artikel |
24 |
Taking the next step in cardiovascular risk reduction: Integrating heart failure and peripheral arterial disease prevention
|
Matasic, Daniel S. |
|
|
266 |
C |
p. 176-178 |
artikel |